Beam Therapeutics, Inc. (BEAM)

27.47 -0.12 (-0.43%) USD  |  NASDAQ  |  Feb 23, 11:07
More

Beam Therapeutics Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for BEAM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
Pacific Biosciences of California, Inc. --
Stryker Corp. Upgrade
Zimmer Biomet Holdings, Inc. Upgrade